This is the first systematic review to assess progressive brain changes and neurocognitive decline in patients with PTSD in addition to evaluating other parameters such as inflammatory pattern, oxidative stress, and neurotrophins according to the concept of neuroprogression. The gene discussed is BDNF; the disease is post-traumatic stress disorder.